Trump’s partial tariff pause could suggests a floor on how low equities can go before triggering a policy pivot. But investors should beware.

Stocks were set to edge higher on Wednesday, having racked up solid gains the previous session thanks to a cooler-than-expected inflation reading and news of artificial intelligence investments from Saudi Arabia.

On two occasions now, Trump has gotten in front of major trade announcements and urged investors to buy stocks.

Shares of pharmaceutical companies were under pressure ahead of Monday’s open after President Donald Trump said he will sign an executive order to slash prescription-drug prices. In a post on his Truth Social platform on Sunday,

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved drugs, analysts say.

Rep. Jared Moskowitz bought tens of thousands of dollars in stock in 20 different companies just two days before Trump announced a tariff pause.

Palantir's stock is seeing a boost from reports that the U.S. and Saudi Arabian governments have reached a new deal that could create significant new business opportunities in the Middle East for the artificial intelligence (AI)-fueled data analytics company.

Drugmakers' shares fell globally after President Trump said he would [sign an executive order](

By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to implement and face legal challenges.

American Bitcoin, the crypto mining firm backed by the Trump family, is set to go public through a merger with another crypto mining firm Gryphon Digital Mining (Nasdaq: GRYP), Hut 8 (Nasdaq: HUT) said on May 12.